The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
(R)-6-(4-fluorophenoxy)-3-((1-isopropylpiperidin-3-yl)methyl)-2-o-tolylquinazolin-4(3H)-one ID: ALA266907
PubChem CID: 44428657
Max Phase: Preclinical
Molecular Formula: C30H32FN3O2
Molecular Weight: 485.60
Molecule Type: Small molecule
This compound is available for customization.
Associated Items:
Names and Identifiers Canonical SMILES: Cc1ccccc1-c1nc2ccc(Oc3ccc(F)cc3)cc2c(=O)n1C[C@@H]1CCCN(C(C)C)C1
Standard InChI: InChI=1S/C30H32FN3O2/c1-20(2)33-16-6-8-22(18-33)19-34-29(26-9-5-4-7-21(26)3)32-28-15-14-25(17-27(28)30(34)35)36-24-12-10-23(31)11-13-24/h4-5,7,9-15,17,20,22H,6,8,16,18-19H2,1-3H3/t22-/m1/s1
Standard InChI Key: KYGGFRZALCCXKR-JOCHJYFZSA-N
Molfile:
RDKit 2D
36 40 0 0 1 0 0 0 0 0999 V2000
9.5250 -16.2417 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
9.5250 -17.0667 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
10.2370 -17.4750 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
10.2370 -15.8250 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
10.9490 -16.2417 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
10.9455 -17.0667 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
11.6543 -17.4799 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
12.3711 -17.0727 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
12.3746 -16.2477 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
11.6613 -15.8299 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.8093 -15.8313 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.8069 -15.0063 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.5255 -14.5944 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.5250 -13.7730 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
8.8112 -13.3587 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.0961 -13.7721 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.0948 -14.5997 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
10.2398 -13.3611 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
10.9540 -13.7742 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
10.2370 -15.0000 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
8.8121 -17.4807 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.0967 -17.0675 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.3833 -17.4803 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.3841 -18.3062 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.1042 -18.7175 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.8146 -18.3023 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.5308 -18.7118 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
13.0912 -15.8390 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
13.8035 -16.2552 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
13.7970 -17.0802 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
14.5085 -17.4964 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
15.2261 -17.0876 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
15.2278 -16.2583 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
14.5158 -15.8459 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
15.9390 -17.5029 0.0000 F 0 0 0 0 0 0 0 0 0 0 0 0
10.2405 -12.5361 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
16 17 1 0
5 10 2 0
14 18 1 0
6 7 2 0
18 19 1 0
7 8 1 0
4 20 2 0
8 9 2 0
9 10 1 0
21 22 2 0
5 6 1 0
22 23 1 0
1 11 1 0
23 24 2 0
24 25 1 0
12 11 1 6
25 26 2 0
26 21 1 0
2 21 1 0
12 13 1 0
26 27 1 0
1 2 1 0
9 28 1 0
1 4 1 0
28 29 1 0
2 3 2 0
29 30 2 0
3 6 1 0
30 31 1 0
5 4 1 0
31 32 2 0
12 17 1 0
32 33 1 0
13 14 1 0
33 34 2 0
34 29 1 0
14 15 1 0
32 35 1 0
15 16 1 0
18 36 1 0
M END Associated Targets(non-human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 485.60Molecular Weight (Monoisotopic): 485.2479AlogP: 6.42#Rotatable Bonds: 6Polar Surface Area: 47.36Molecular Species: BASEHBA: 5HBD: ┄#RO5 Violations: 1HBA (Lipinski): 5HBD (Lipinski): ┄#RO5 Violations (Lipinski): 1CX Acidic pKa: ┄CX Basic pKa: 9.14CX LogP: 6.31CX LogD: 4.57Aromatic Rings: 4Heavy Atoms: 36QED Weighted: 0.32Np Likeness Score: -1.32
References 1. Rudolph J, Esler WP, O'connor S, Coish PD, Wickens PL, Brands M, Bierer DE, Bloomquist BT, Bondar G, Chen L, Chuang CY, Claus TH, Fathi Z, Fu W, Khire UR, Kristie JA, Liu XG, Lowe DB, McClure AC, Michels M, Ortiz AA, Ramsden PD, Schoenleber RW, Shelekhin TE, Vakalopoulos A, Tang W, Wang L, Yi L, Gardell SJ, Livingston JN, Sweet LJ, Bullock WH.. (2007) Quinazolinone derivatives as orally available ghrelin receptor antagonists for the treatment of diabetes and obesity., 50 (21): [PMID:17887659 ] [10.1021/jm070071+ ]